Tian Tang | Nanodrug | Best Researcher Award

Published on by China Scientist

Prof. Tian Tang | Nanodrug | Best Researcher Award 

Dr. Tian Tang is an Associate Chief Physician at the Department of Reproductive Medicine, West China Second Hospital, Sichuan University. She holds a Doctorate in Obstetrics and Gynecology and a Bachelor’s degree in Clinical Medicine from Sichuan University. Her research focuses on assisted reproductive technology, ovarian function, and gynecologic cancer, with particular interest in gene polymorphisms and chemotherapy resistance. Dr. Tang has led and participated in several national and regional research projects and has published extensively in peer-reviewed journals. She is also a holder of a Chinese patent related to neurodevelopmental disease modeling.

Prof. Tian Tang | Sichuan University | China

Profile

🎓Education

  • Tian Tang completed her Bachelor of Clinical Medicine at the West China School of Medicine, Sichuan University, between September 2008 and July 2013. Following this, she pursued a Doctorate in Obstetrics and Gynecology at the same institution from September 2013 to July 2016. Her educational background has provided a strong foundation for her expertise in reproductive medicine and gynecologic oncology.

👨‍🏫 Experience

  • Dr. Tian Tang currently serves as an Associate Chief Physician in the Department of Reproductive Medicine at West China Second Hospital, Sichuan University, a position she has held since September 2021. She previously worked as an Attending Physician in the same department from September 2018 to August 2021. Her career began as a Physician at the West China Second Hospital from July 2016 to August 2018. Over these years, Dr. Tang has accumulated extensive clinical and research experience in assisted reproduction and gynecologic cancer treatment.

🤝 Awards and Recognition

  • Dr. Tang has made notable contributions to reproductive health and oncology research. Her work has been published in high-impact journals such as Pathology and Oncology Research, Journal of Molecular Liquids, Singapore Medical Journal, and the Latin American Journal of Pharmacy. She has also contributed to innovation through intellectual property, including a 2023 Chinese patent on constructing animal models for autism-related studies. Her clinical insights and scientific rigor have been recognized through multiple funded research grants, highlighting her role as both a leading clinician and an accomplished researcher in reproductive medicine.

💡Skills and Certifications

  • Tian Tang possesses a broad and interdisciplinary skill set that spans clinical reproductive medicine, molecular oncology, and biomedical research. Her expertise includes designing and executing randomized controlled trials, analyzing gene expression and signaling pathways, managing multidisciplinary research teams, and translating benchside discoveries into clinical applications. Her collaborative work across national research platforms and health promotion foundations underlines her leadership in advancing evidence-based reproductive health interventions.

🔬 Research Focus

  • Dr. Tian Tang’s research centers on reproductive medicine, with a specific emphasis on assisted reproductive technology (ART), ovarian function, and gynecological cancers such as endometrial and cervical cancer. Her studies have explored molecular mechanisms such as MAPK signaling pathways, gene polymorphisms (LH/LHCGR and BRCA), and chemotherapy resistance. She is also involved in clinical investigations assessing the effects of recombinant luteinizing hormone (rLH) on ART outcomes in genetically diverse populations. Her multidisciplinary approach integrates molecular biology, pharmacology, and clinical trial methodologies.

🌎Conclusion

  • Dr. Tian Tang exemplifies the qualities of a Best Researcher Award recipient through her visionary leadership, impactful research, and translational success in reproductive and precision medicine. Her contributions bridge the gap between clinical need and scientific innovation, making her a highly deserving candidate for this honor. Recognizing her with this award would not only validate her scientific excellence but also inspire future innovation in women’s health and reproductive science.

📖Publications

Title: Independent predictors and thresholds of in vitro fertilization outcomes in patients with diminished ovarian reserve
Authors: Yanru Zeng, Ying Zhang, Qi Cao, Zhan Gao, Tian Tang
Journal: Scientific Reports

Title: LncRNA HEIH Enhances Paclitaxel-Tolerance of Endometrial Cancer Cells via Activation of MAPK Signaling Pathway
Authors: Jun-Liang Guo, Tian Tang, Jin-Hong Li, Yi-Hong Yang, Long Zhang, Yi Quan
Journal: Pathology and Oncology Research

Title: Dihydroartemisinin exerts its anti-cancer activity in endometrial carcinoma and cervical cancer: involvement of apoptosis, autophagy, and transferrin receptor
Authors: Tian Tang, Qingjie Xia, Mingrong Xi
Journal: Singapore Medical Journal

Title: Recombinant Luteinizing Hormone (LH) Supplementation Improves Controlled Ovarian Hyperstimulation Outcome in Women with Low LH Concentration During Mid- and Late-Follicular Phase
Authors: Huili Zhu, Qiming Wang, Wei Huang, Yuechao Lu, Tian Tang
Journal: Latin American Journal of Pharmacy